Q32 Bio Inc. SEC filings QTTB

Q32 Bio Inc. has 588 filings in SEC EDGAR's recent list, going back to Jan 6, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Q32 Bio Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 28, 2026 —
4 Insider transaction Oct 14, 2026 Oct 6, 2026
4 Insider transaction Oct 14, 2026 Oct 6, 2026
4 Insider transaction Oct 14, 2026 Oct 6, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 9, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Sep 30, 2026 Sep 30, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 14, 2026 Sep 14, 2026
4 Insider transaction Aug 27, 2026 Aug 25, 2026
4 Insider transaction Aug 27, 2026 Aug 25, 2026
4 Insider transaction Aug 27, 2026 Aug 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
EFFECT Filing Jul 28, 2026 —
424B3 Prospectus Jul 28, 2026 —
4/A Filing Jul 21, 2026 Jun 12, 2026
4/A Filing Jul 21, 2026 Jun 12, 2026
4/A Filing Jul 21, 2026 Jun 12, 2026
4/A Filing Jul 21, 2026 Jun 12, 2026
4/A Filing Jul 21, 2026 Jun 12, 2026
4/A Filing Jul 21, 2026 Jun 12, 2026
4/A Filing Jul 21, 2026 Jun 12, 2026
4/A Filing Jul 21, 2026 Jun 12, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 20, 2026 —
4 Insider transaction Jul 20, 2026 Jul 16, 2026
4 Insider transaction Jul 20, 2026 Jul 16, 2026
4 Insider transaction Jul 20, 2026 Jul 16, 2026
S-3 Shelf registration Jul 17, 2026 —
8-K Current report
Material agreement
Jul 15, 2026 Jul 14, 2026
424B5 Prospectus supplement Jul 15, 2026 —
EFFECT Filing Jul 13, 2026 —
424B5 Prospectus supplement Jul 13, 2026 —
8-K Current report
Other events
Jul 13, 2026 Jul 13, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 13, 2026 Jul 13, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 6, 2026 —
4 Insider transaction Jul 2, 2026 Jun 30, 2026
S-3 Shelf registration Jun 25, 2026 —
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
8-K Current report
Shareholder vote results
Jun 16, 2026 Jun 12, 2026
3 Initial insider ownership Jun 8, 2026 May 26, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jun 4, 2026 —
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 1, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) May 28, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
May 27, 2026 May 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) May 6, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 12, 2026
8-K Current report
Other events
Apr 24, 2026 Apr 24, 2026
424B5 Prospectus supplement Apr 24, 2026 —
8-K Current report
Material agreement
Mar 27, 2026 Mar 27, 2026
424B5 Prospectus supplement Mar 27, 2026 —
4 Insider transaction Mar 20, 2026 Feb 24, 2026
4 Insider transaction Mar 20, 2026 Feb 24, 2026
4 Insider transaction Mar 20, 2026 Feb 24, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 12, 2026 —
S-8 Employee stock plan registration Mar 10, 2026 —
10-K Annual report Mar 10, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 10, 2026 Mar 10, 2026
4 Insider transaction Feb 27, 2026 Feb 25, 2026
4 Insider transaction Feb 27, 2026 Feb 25, 2026
4 Insider transaction Feb 27, 2026 Feb 25, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 20, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 19, 2026 —
8-K Current report
Material agreement, Other events
Feb 17, 2026 Feb 17, 2026
424B5 Prospectus supplement Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
4 Insider transaction Jan 30, 2026 Jan 15, 2026
4 Insider transaction Jan 30, 2026 Jan 15, 2026
4 Insider transaction Jan 30, 2026 Jan 15, 2026
8-K Current report
Officer or director change
Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
144 Notice of proposed sale Dec 2, 2025 —
144 Notice of proposed sale Dec 2, 2025 —
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Regulation FD disclosure, Other events
Dec 1, 2025 Nov 28, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
4 Insider transaction Oct 27, 2025 Oct 23, 2025
4 Insider transaction Oct 27, 2025 Oct 23, 2025
4 Insider transaction Oct 27, 2025 Oct 23, 2025
4 Insider transaction Oct 27, 2025 Oct 23, 2025
4 Insider transaction Oct 27, 2025 Oct 23, 2025
4 Insider transaction Oct 27, 2025 Oct 23, 2025
4 Insider transaction Oct 27, 2025 Oct 23, 2025
4 Insider transaction Oct 27, 2025 Oct 23, 2025
8-K Current report
Other events
Oct 21, 2025 Oct 21, 2025
4 Insider transaction Aug 28, 2025 Aug 26, 2025
4 Insider transaction Aug 28, 2025 Aug 26, 2025
4 Insider transaction Aug 28, 2025 Aug 26, 2025
UPLOAD Letter from the SEC Aug 28, 2025 —
CORRESP Letter to the SEC Aug 26, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
CORRESP Letter to the SEC Jul 31, 2025 —
UPLOAD Letter from the SEC Jul 30, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 25, 2025 Jun 20, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Jun 17, 2025 Jun 13, 2025
8-K Current report
Listing notice
May 23, 2025 May 19, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 13, 2025
8-K Current report
Officer or director change
Apr 25, 2025 Apr 25, 2025
EFFECT Filing Apr 21, 2025 —
CORRESP Letter to the SEC Apr 17, 2025 —
EFFECT Filing Apr 16, 2025 —
UPLOAD Letter from the SEC Apr 16, 2025 —
POS AM Filing Apr 11, 2025 —
S-3 Shelf registration Apr 11, 2025 —
PRE 14A Preliminary proxy statement Apr 11, 2025 Jun 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 8, 2025 —
S-8 Employee stock plan registration Mar 11, 2025 —
424B3 Prospectus Mar 11, 2025 —
10-K Annual report Mar 11, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 11, 2025 Mar 11, 2025
424B3 Prospectus Mar 10, 2025 —
8-K Current report
Other events
Mar 10, 2025 Mar 8, 2025
4 Insider transaction Feb 27, 2025 Jan 15, 2025
4 Insider transaction Feb 27, 2025 Feb 24, 2025
4 Insider transaction Feb 27, 2025 Feb 24, 2025
4 Insider transaction Feb 27, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Jan 15, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Jan 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
424B3 Prospectus Feb 10, 2025 —
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Feb 10, 2025 Feb 10, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 10, 2025 —
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
424B3 Prospectus Dec 11, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Dec 11, 2024 Dec 10, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 13, 2024 —
424B3 Prospectus Nov 7, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 25, 2024 —
4 Insider transaction Oct 16, 2024 Oct 11, 2024
4 Insider transaction Oct 10, 2024 Oct 8, 2024
4 Insider transaction Sep 30, 2024 Apr 1, 2024
4 Insider transaction Sep 27, 2024 Sep 25, 2024
4 Insider transaction Aug 14, 2024 Apr 1, 2024
4 Insider transaction Aug 14, 2024 Mar 25, 2024
424B3 Prospectus Aug 8, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
424B3 Prospectus Jul 9, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jul 9, 2024 Jul 9, 2024
S-8 Employee stock plan registration May 31, 2024 —
SC 13G/A Amended ownership over 5% (passive) May 13, 2024 —
424B3 Prospectus May 9, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
EFFECT Filing Apr 29, 2024 —
424B3 Prospectus Apr 29, 2024 —
CORRESP Letter to the SEC Apr 25, 2024 —
UPLOAD Letter from the SEC Apr 25, 2024 —
4 Insider transaction Apr 23, 2024 Mar 25, 2024
4 Insider transaction Apr 23, 2024 Mar 25, 2024
S-1 Registration statement Apr 19, 2024 —
10-K/A Amended annual report Apr 12, 2024 Dec 31, 2023
SC 13D Ownership over 5% (active) Apr 4, 2024 —
SC 13D Ownership over 5% (active) Apr 1, 2024 —
SC 13G Ownership over 5% (passive) Mar 29, 2024 —
SC 13D Ownership over 5% (active) Mar 28, 2024 —
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
QTTB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1661998
Former names
Q32 Bio Inc. (until Nov 4, 2026); Homology Medicines, Inc. (until Mar 22, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.